Why the study?
Maternal antibodies may interfere with the response to foot-and-mouth disease vaccination in calves, affecting immunization effectiveness.
Does a two-dose vaccination regime improve neutralising virus antibody responses in calves with maternal antibodies compared to a single dose?
Cohort (n=99)
No
Does a two-dose vaccination regime improve neutralising virus antibody responses in calves with maternal antibodies compared to a single dose?
In calves with maternal antibodies, a two-dose FMD vaccination regimen is necessary to achieve effective immunization, and pre-existing antibodies may modulate the specificity of active antibody responses.
Answers are grounded in this paper and cite their sources.
May support two-dose FMD regimens in calves with maternal antibodies; leaves open translation to field conditions or other species.
Vaccination is widely used to control foot-and-mouth disease (FMD), but maternal antibodies may interfere with the response to vaccination in calves. This study, conducted on a regularly vaccinated Malaysian dairy farm, aimed to optimise the vaccination regime by measuring the in vitro neutralising virus antibody responses of 51 calves before and after vaccination with a one or two dose vaccination regime starting at 2-7 months old. The presence of maternal antibodies was associated with poor post-vaccination antibody responses after a single dose of vaccine in calves less than 6 months old. However, a second dose of vaccine given three weeks later, improved the antibody responses in all ages of calves. This confirms the view that in regularly vaccinated farms, some combination of delay and revaccination is needed to achieve effective immunization of calves. Sera from cows and pre-vaccinated calves neutralised homologous serotype A vaccine virus more strongly than a heterologous serotype A field virus, but this pattern was reversed in some calves after vaccination. The strength of heterologous responses in calves 49 days after first vaccination correlated to the amount of transferred maternal antibody, suggesting that pre-existing antibodies could have modulated the specificity of these active antibody responses. If confirmed, such an effect by pre-existing antibodies could have wider implications for broadening the coverage of FMD vaccine responses.
No takes yet. Share an insight, caveat, or question.
Senawi et al. (2023) conducted a cohort in Foot-and-mouth disease (FMD) maternal antibody interference (n=99). FMD vaccination (Aftovaxpur) vs. Single dose (unboosted) or baseline was evaluated on Change in homologous neutralising antibody titre (log10) after booster vaccination (MD 1.02, 95% CI 0.74-1.30).
Synapse has enriched 10 related papers. Consider them for comparative context: